Title: Vice President, Safety Assessment Sales
Company: Inotiv
Education: Master of Business Administration– UNC Chapel Hill; BS Biology—Bucknell University
Vertical: Pharmaceuticals & Life Sciences
Fun Fact: I have traveled to 6 of the 7 continents in the world. Just Antarctica to go!
Career Switcher: Yes, early in my career. I was in Higher Education prior to Business School. After Business School I have been in the drug development field, first on the pharmaceutical side and then on the CRO side.
Hometown: Hyde Park, NY
Current City: Rockville, MD
Ask me about: Anything having to do with drug development, either within a pharmaceutical company or within a CRO. I have worked from the discovery space (pre-clinical) all the way through clinical and through to launch and beyond of a new product.
Biography: Lynn Lewis is Chief Commercial Officer for Emmes, a leading clinical Contract Research Organization supporting both private and public research. In this role, she is responsible for directing all commercial activities globally including sales, marketing, communications, and customer engagement. Lynn brings extensive knowledge in both science and business to the company through her successful career in pharmaceuticals, and leadership roles within sales and operations in the contract research organization (CRO) industry.
Prior to joining Emmes, Lynn was CCO for Envigo, a large non-clinical CRO. And, before that, Lynn was Group Vice President of Business Development for Covance. During her 15 year career with Covance, she also led the global sales organizations for Covance’s nonclinical and central laboratory businesses and also served as the General Manager of Covance’s drug discovery and development campus in Greenfield, Indiana.
Lynn also worked for Eli Lilly and Company for 16 years before Covance leading crossfunctional development teams to bring new medicines to market. She held various positionsin sales, marketing, strategic planning, and general management. Her last position wasProduct Team Leader for two of Lilly’s osteoporosis compounds. In this position, she led ateam of scientific and commercial professionals through submission and approval of Forteoin the US and Europe. She also spent two years abroad as General Manager for their Danishaffiliate.
Mrs. Lewis’ background includes a MBA from the University of North Carolina – Chapel Hill, and a B.S. in Biology from Bucknell University. She has served on several community boards, including BioCrossroads’ External Advisory Board, Healthcare Businesswomen’s Association External Advisory Committee, Bucknell University’s Alumni Board of Directors and UNC Kenan-Flagler’s Board of Visitors.
